Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05762588 · ClinicalTrials.gov registry record

JuggerKnot With Broadband PMCF Study

A clinical trial of Knee Injuries and Shoulder Injuries, sponsored by Riverpoint Medical.

Active
Registry status
30
Enrollment target
1
Study location

NCT05762588: Active study of Knee Injuries and Shoulder Injuries, sponsored by Riverpoint Medical.

NCT05762588 is a study of Knee Injuries and Shoulder Injuries that is active but no longer recruiting, run by Riverpoint Medical. The registered enrollment target is 30 participants, below the 176-participant average among 14 other Knee Injuries trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05762588, a study of Knee Injuries and Shoulder Injuries, is active but no longer recruiting, sponsored by Riverpoint Medical.

ACTIVE NOT RECRUITING
Registry status
30 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to collect post-market clinical follow-up data, which is needed to confirm the safety and performance of the JuggerKnot device and meet existing EU regulatory requirements.

Primary Outcome

Defined as freedom from reintervention due to JuggerKnot with BroadBand failure. Absence of device migration loosening or pull-out.

Interventions

  • DEVICE Juggerknot with Broadband tape

Study Locations (1)

Maryland

  • MedStar Health Research Institute - Hyattsville

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2023-11-30
Est. Completion 2025-12-30
Riverpoint Medical

1 total trials

What the registry record for NCT05762588 still lists

NCT05762588 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 176-participant average among 14 other Knee Injuries trials with a reported enrollment target (83% lower).

The record links to 5 conditions, with Knee Injuries appearing as the primary indexed condition, and to 1 intervention - of which Juggerknot with Broadband tape is the first listed.

NCT05762588 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT05762588 about?

NCT05762588 is a clinical study titled "JuggerKnot With Broadband PMCF Study". The purpose of the study is to collect post-market clinical follow-up data, which is needed to confirm the safety and performance of the JuggerKnot device and meet existing EU regulatory requirements.

What is the current status of trial NCT05762588?

This trial is currently active not recruiting. The enrollment target is 30 participants. The study started on 2023-11-30. Estimated completion is 2025-12-30.

What conditions does trial NCT05762588 study?

This clinical trial studies the following conditions: Knee Injuries, Shoulder Injuries, Hip Injuries, Ankle Injuries, Foot Injury.

What interventions are being tested in trial NCT05762588?

The interventions under investigation include: Juggerknot with Broadband tape (DEVICE).

Who is sponsoring clinical trial NCT05762588?

This trial is sponsored by Riverpoint Medical, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05762588 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Knee Injuries

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05762588's enrollment target sits among peer trials

30 12th of 14 higher than 1 of 14 other Knee Injuries trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Knee Injuries trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05762588, the US trial registry maintained by the National Library of Medicine. NCT05762588 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.